Edited Transcript of PFSW earnings conference call or presentation 7-May-20 9:00pm GMT

batucity

Plano May 9, 2020 (Thomson StreetEvents) — Edited Transcript of PFSweb Inc earnings conference call or presentation Thursday, May 7, 2020 at 9:00:00pm GMT

PFSweb, Inc. – Executive VP & GM of LiveArea

* Michael C. Willoughby

PFSweb, Inc. – CEO & Director

* R. Zach Thomann

PFSweb, Inc. – Executive VP & GM of PFS

* Thomas J. Madden

PFSweb, Inc. – Executive VP & CFO

Lake Street Capital Markets, LLC, Research Division – Senior Research Analyst, Founding Partner & Head of Institutional Equities

Good afternoon, everyone, and thank you for participating in today’s conference call to discuss PFSweb’s Financial Results for First Quarter ended March 31, 2020. Joining us today are PFSweb CEO, Mike Willoughby; the company’s CFO, Tom Madden; the General Manager of PFS, Zach Thomann; and the General Manager of LiveArea, Jim Butler. Following their remarks, we’ll open the call for your questions.

Before we go … Read More

A Week In Chicago, IL, On A $230,961 Salary

batucity

Welcome to Money Diaries, where we’re tackling what might be the last taboo facing modern working women: money. We’re asking women how they spend their hard-earned money during a seven-day period — and we’re tracking every last dollar.

Today: an Associate General Counsel who makes $230,961 per year spends some of her money this week on a palm plant.

Occupation: Associate General Counsel
Industry: Healthcare
Age: 36
Location: Chicago, IL
Salary: $230,961.28 (plus $23,000-$46,000 annual bonus)
Net Worth: approx. $455,000, which includes investments (i.e., IRA, 403(b), and additional investment accounts), savings, and real estate and no debt
Debt: $0 (thanks to scholarships for college and law school and aggressive repayment of comparatively low law school debt)
Paycheck Amount (biweekly): $5,225 (after taxes and other payroll deductions)
Pronouns: She/her

Monthly Expenses
Rent: $3,390 for a two-bedroom/two-bathroom apartment for me and my robot vacuum
Loans: $0
Cable & Internet: $176
Medical Read More

Edited Transcript of MSTR earnings conference call or presentation 28-Apr-20 9:00pm GMT

batucity

VIENNA Apr 30, 2020 (Thomson StreetEvents) — Edited Transcript of MicroStrategy Inc earnings conference call or presentation Tuesday, April 28, 2020 at 9:00:00pm GMT

* Michael J. Saylor

* Phong Q. Le

BWS Financial Inc. – Principal & Research Analyst

Ladies and gentlemen, thank you for standing by, and welcome to the MicroStrategy Q1 2020 Earnings Call. (Operator Instructions) Please be advised that today’s conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Michael Saylor, Chairman, President and CEO. Please go ahead.

Michael J. Saylor, MicroStrategy Incorporated – Chairman, CEO & President [2]

Hello. This is Michael Saylor. I’m the Chairman, President and CEO of MicroStrategy. I’d like to welcome all of you to today’s conference call regarding our 2020 first quarter financial results. This has been quite an unusual and eventful quarter for the world, and for MicroStrategy, we … Read More

Are Biotech ETFs in Trouble as Coronavirus Dims Guidance?

batucity

The coronavirus has infected more than three million people across the globe. The death toll has surpassed 269,000 worldwide, according to Johns Hopkins University. In such a scenario, the desperation for a vaccine or treatment is rising by the hour. The race to introduce vaccine and treatment for coronavirus is opening up opportunities, making the biotech sector a prospective space for investments. From positive news related to Gilead Sciences’ remdesivir to progress in development of cell therapies for the treatment of COVID-19, these developments have kept the sector surging.

Although the coronavirus outbreak seems to be opening up opportunities for biotech companies, it is dampening their guidance as well. Despite delivering impressive results, most of the following biotech companies have been seeing declining share prices since the earnings releases largely due to coronavirus-hit outlooks. Let’s take a look at some big biotechnological earnings releases to see if these will impact

Read More